National Healthcare Properties, Inc.(NHP)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
2-STAR RATING
PASS
LAST CLOSE
$15.04
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for NHP

11/13/2026: NHP (2-star) is currently NOT-A-BUY. Pass it for now.

National Healthcare Properties, Inc. (NHP) is a self-managed healthcare REIT focused on the needs-based senior housing and outpatient medical sectors. Following its 2024 internalization, the company has prioritized deleveraging and asset optimization to build an investment-grade balance sheet. Its main strength lies in its exposure to the growing aging population, which drives stable demand for its residential and medical assets. While it offers growth potential, investors should be aware of risks related to its smaller scale, historical net losses, and interest rate sensitivity. NHP may suit growth-oriented investors looking for exposure to essential healthcare infrastructure, though monitoring the progress of its current deleveraging and disposition initiatives remains critical.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fit while signal remains positiveThe company is actively pursuing aggressive acquisition pipelines in the high-demand senior housing sector.
Momentum investorMixed fitRequires positive price trend confirmation before entry as the stock is sensitive to interest rate fluctuations.
Value investorStrong fitCurrent pricing and focus on asset divestitures to reach investment-grade status may offer value if deleveraging succeeds.
Dividend investorMixed fitDividends are present, but the payout ratio and REIT classification suggest an emphasis on total return rather than yield safety.
Low-risk investorWeak fitHigh price volatility and recent negative net income metrics represent higher risks than stable, blue-chip REITs.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock has experienced significant price swings reflecting its growth-stage REIT status and sector sensitivity.
Valuation riskMedium / highMarket expectations for growth must be met to justify current price-to-sales ratios.
Competition risk (REIT scale)Medium / highThe company faces significant capital cost disadvantages against larger, well-established healthcare REIT peers.
Business qualityMediumThe company's focus on essential senior care provides a defensive quality, offset by recent net losses.
Dividend incomeMediumDividends are maintained, but future sustainability depends on successful portfolio optimization and FFO growth.
Execution riskMedium / highManagement must successfully integrate assets and execute divestitures to reach investment-grade targets.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.10B USD
Price to earnings Ratio -
1Y Target Price 19.57
Price to earnings Ratio -
1Y Target Price 19.57
Volume (30-day avg) 1.3M shares
Beta 462.07
52 Weeks Range 11.14 - 17.37
Updated Date 11/14/2026
52 Weeks Range 11.14 - 17.37
Updated Date 11/14/2026
Dividends yield (FY) 1.98%
Basic EPS (TTM) -0.87

Sector & Industry Intelligence

Sector

Real Estate

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
64.5%
Active BUY / eligible
20 / 31
30-Day BUY Count Change
+16
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

REIT - Healthcare Facilities

BUY participation
100.0%
Active BUY / eligible
4 / 4
30-Day BUY Count Change
+4

Eligible universe: 4 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Rolling Over
PRICE PATH

Rolling Over

The price momentum is slowing down and beginning to turn downward.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 5.44%
Avg. Invested days 70
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 5.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
NHP receives a 3-star rating, supported by solid analyst coverage. The rating is constrained by weak unit economics, and weak price momentum.

Company Fundamentals

★★★★★
NHP has moderate overall fundamentals (3 stars), with soft financial health, solid growth momentum, and solid ownership. In FY2025 versus FY2024, strong earnings growth (+69.6%) is partially offset by weak cash generation (FCF margin -6.4%), slightly negative revenue growth (-3.3%), weak profitability (net margin -16.8%).

Financial Health Rating

★★★★★
NHP's financial health is soft, with the relatively strongest area being moderate efficiency, including operating-expense and cost-of-revenue discipline (opex 35.1% of revenue). Liquidity is soft (2 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is NHP's strongest growth driver at +78.6% FY2025 versus FY2024 (strong, 5 stars). By comparison, earnings growth (+69.6%, strong) is also strong, while revenue growth (-3.3%, slightly negative) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 73.7% and approximately 164.3% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership is only 0.19%, which materially reduces the ownership score.

Top 5 Institutional Investors

AllianceBernstein L.P. 6.71%
Prudential Financial Inc 6.18%
Duff & Phelps Inv Mgmt Co (IL) 5.67%
BlackRock Inc 5.27%
LaSalle Investment Management Securities LLC 4.60%

Unit Economics (Per $1K Revenue)

★★★★★
NHP generates approximately $360 of gross profit, $10 of operating income, and $-64 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Negative free cash flow explains the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -0.28% (Tax Credit)

Quantitative Style Profile

★★★★★
NHP has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

High VolatilitySmall / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Senior Housing Operating Properties (SHOP)Rental and operational income from assisted living and memory care facilities.The company earns money from the day-to-day operations of senior living communities.
Outpatient Medical Facilities (OMF)Lease income from medical offices and hospitals.Stable, long-term rent collection from healthcare providers.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-04
When After Market
Estimate 0.41
Actual 0.41

Profitability

Profit Margin -3.37%
Operating Margin (TTM) 7.82%

Management Effectiveness

Return on Assets (TTM) 0.97%
Return on Equity (TTM) -1.57%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 2.52B
Price to Sales(TTM) 3.03
Enterprise Value 2.52B
Price to Sales(TTM) 3.03
Enterprise Value to Revenue 6.96
Enterprise Value to EBITDA 20.75
Shares Outstanding 44.27M
Shares Floating 72.76M
Shares Outstanding 44.27M
Shares Floating 72.76M
Percent Insiders 0.19
Percent Institutions 73.72

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.